Lapatinib Combined With Letrozole Versus Letrozole and Placebo As First-Line Therapy for Postmenopausal Hormone Receptor-Positive Metastatic Breast CancerJOHNSTON, Stephen; PIPPEN, John; PRESS, Michael F et al.Journal of clinical oncology. 2009, Vol 27, Num 33, pp 5538-5546, issn 0732-183X, 9 p.Article

A phase II study of pemetrexed and carboplatin in patients with locally advanced or metastatic breast cancerGARIN, August; MANIKHAS, Alexey; BIAKHOV, Mikhail et al.Breast cancer research and treatment. 2008, Vol 110, Num 2, pp 309-315, issn 0167-6806, 7 p.Article

Effect of tibolone on breast cancer cell proliferation in postmenopausal ER+ patients : Results from STEM trialKUBISTA, Ernst; PLANELLAS GOMEZ, Juan V. M; SINGER, Christian F et al.Clinical cancer research. 2007, Vol 13, Num 14, pp 4185-4190, issn 1078-0432, 6 p.Article

First-Line Trastuzumab Plus Epirubicin and Cyclophosphamide Therapy in Patients With Human Epidermal Growth Factor Receptor 2-Positive Metastatic Breast Cancer: Cardiac Safety and Efficacy Data From the Herceptin, Cyclophosphamide, and Epirubicin (HERCULES) TrialUNTCH, Michael; MUSCHOLL, Michael; HARBECK, Nadia et al.Journal of clinical oncology. 2010, Vol 28, Num 9, pp 1473-1480, issn 0732-183X, 8 p.Article